CAPE-loaded targeted microvesicular anticancer drug and its development method

摘要

The present invention relates to the production of a drug specific for SH-SY5Y neuroblastoma cancer by loading CAPE into the microvesicles that specialized skin cells leave in the nutrient solution. An object of the present invention is to provide the development of cell-specific targeted vesicles by loading CAPE into microvesicles obtained as a result of culturing tissue cells and subsequent specialization (differentiation); and the latest. The use of CAPE at lower concentrations compared to its use is to minimize its toxicity to both non-target cells and the body.